(Q39441043)

English

Longitudinal analysis of frequency and reactivity of Epstein-Barr virus-specific T lymphocytes and their association with intermittent viral reactivation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Longitudinal analysis of frequency and reactivity of Epstein-Barr virus-specific T lymphocytes and their association with intermittent viral reactivation (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

0 references

Epstein–Barr virus

0 references

author name string

Bastian A Vogl

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Ursula Fagin

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Linda Nerbas

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Peter Schlenke

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Peter Lamprecht

5

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Wolfram J Jabs

6

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

publication date

1 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Journal of Medical Virology

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

84

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

119-131

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

Phenotypic analysis of antigen-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

Reactivation of Epstein-Barr virus from latency

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

Management of Epstein-Barr virus (EBV) reactivation after allogeneic stem cell transplantation by simultaneous analysis of EBV DNA load and EBV-specific T cell reconstitution.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

Analysis of intracellular cytokines using flowcytometry

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3)

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

Five new cytotoxic T cell epitopes identified within Epstein-Barr virus nuclear antigen 3.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

CD8+ T cells specific for EBV, cytomegalovirus, and influenza virus are activated during primary HIV infection.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

Regression of Epstein-Barr virus-induced B-cell transformation in vitro involves virus-specific CD8+ T cells as the principal effectors and a novel CD4+ T-cell reactivity

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

Virus-specific CD4+ T cells: ready for direct attack

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

IL-8 responsiveness defines a subset of CD8 T cells poised to kill.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

Characterization of two Epstein-Barr virus epitopes restricted by HLA-B7.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

Tonsillar homing of Epstein-Barr virus-specific CD8+ T cells and the virus-host balance

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

Distribution and phenotype of Epstein-Barr virus-infected cells in human pharyngeal tonsils

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

Detection of lymphocytes productively infected with Epstein-Barr virus in non-neoplastic tonsils

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

Detection of Epstein-Barr virus in salivas and throat washings in healthy adults and children

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

Normalized quantification by real-time PCR of Epstein-Barr virus load in patients at risk for posttransplant lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

Role of cytotoxic T lymphocytes in Epstein-Barr virus-associated diseases

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

Quantification and characterization of specific T-cells by antigen-specific cytokine production using ELISPOT assay or intracellular cytokine staining

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

Dynamic EBV gene loads in renal, hepatic, and cardiothoracic transplant recipients as determined by real-time PCR light cycler.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

Molecular parameters for precise diagnosis of asymptomatic Epstein-Barr virus reactivation in healthy carriers

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

Identification of major histocompatibility complex class II-restricted antigens and epitopes of the Epstein-Barr virus by a novel bacterial expression cloning approach

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

The role of Epstein-Barr virus in cancer

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

A global appraisal of immunodominant CD8 T cell responses to Epstein-Barr virus and cytomegalovirus by bulk screening

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

Application of virus-specific immunoglobulin M (IgM), IgG, and IgA antibody detection with a polyantigenic enzyme-linked immunosorbent assay for diagnosis of Epstein-Barr virus infections in childhood

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

Human immunodeficiency virus type 1- and cytomegalovirus-specific cytotoxic T lymphocytes can persist at high frequency for prolonged periods in the absence of circulating peripheral CD4(+) T cells.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

Quantitation of CD8+ T cell responses to newly identified HLA-A*0201-restricted T cell epitopes conserved among vaccinia and variola (smallpox) viruses

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

MHC class II tetramers containing influenza hemagglutinin and EBV EBNA1 epitopes detect reliably specific CD4(+) T cells in healthy volunteers

1 reference

https://api.crossref.org/works/10.1002%2FJMV.22258

21 January 2018

Identifiers

10.1002/JMV.22258

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39441043&oldid=1828019639"